1st Detect, An Astrotech Corp Subsidiary, Secures Significant Purchase Order For Additional Checkpoint Security Units; No Financial Terms Disclosed

Astrotech Corporation (NASDAQ:ASTC) announced today that its 1st Detect subsidiary has accepted another significant purchase order for seven of its TRACER 1000™ explosives trace detectors (ETDs), for an airport

Astrotech Corporation (NASDAQ:ASTC) announced today that its 1st Detect subsidiary has accepted another significant purchase order for seven of its TRACER 1000™ explosives trace detectors (ETDs), for an airport security checkpoint. The systems will be deployed in a European airport in Romania.

 

“We’re excited to begin Fiscal Year 2024 with increased sales and interest in the TRACER 1000 from the security checkpoint field. Based on the near-zero false alarm rate that mass spectrometry provides, we believe that the TRACER 1000 improves checkpoint efficiency and passenger throughput by reducing the need for time-consuming pat-downs,” said Thomas B. Pickens III, Chairman and Chief Executive Officer of 1st Detect.

The Astrotech Mass Spectrometer Technology™ (AMS Technology) drives the breakthrough TRACER 1000, the first certified ETD to employ mass spectrometry. Recognized as the gold standard in chemical detection, mass spectrometry has historically been too costly, bulky, and cumbersome to be used outside of the laboratory. Unlike other technologies, the AMS Technology works under ultra-high vacuum, which eliminates competing molecules that can impair the accuracy and quality of an analysis. The TRACER 1000 is inexpensive, small, and easy to use, with high resolution and near-zero false alarms. Due to its high sensitivity and rugged design, the TRACER 1000 is the only mass spectrometry-based ETD to have received European Civil Aviation Conference (ECAC) certification for both checkpoint and cargo security.

Total
0
Shares
Related Posts
Read More

MariMed Is On A Roll: Partners With Two Iconic Music Venues In Boston, Acquires Another Illinois Cannabis Dispensary

Multi-state marijuana operator MariMed has closed the acquisition of Allgreens Dispensary, LLC on Tuesday, April 9, its fifth dispensary in Illinois. The Massachusetts-based company said the green light from the Illinois Department of Financial & Professional Regulation for the license transfer and subsequent closing of the acquisition, allows MariMed to fully consolidate the financial results of the company's Thrive-branded dispensary in Casey, Illinois. Previously, the dispensary has been operated under a managed services agreement. The move comes on the heels of MariMed's last week's acquisition of the operating assets of Our Community Wellness & Compassionate Care Center in Prince George's County in Maryland. Jon Levine, MariMed's CEO and one of the speakers at the Benzinga Cannabis Capital Conference next week, said "maximizing our footprint there [in Maryland] has long been one of our top strategic priorities."

CSE:MRMD